Ipamorelin

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide that acts as an agonist of the GHS-R1a receptor — the same receptor to which ghrelin binds, a hormone that, among other things, stimulates hunger and growth hormone secretion. It belongs to the group of GH secretagogues, but not to the growth hormone analogues.

In research it is described as a relatively selective compound, which means that in certain models it stimulates growth hormone secretion without affecting other hormones such as cortisol or prolactin to the same degree. This selectivity is often a starting point for further studies, but it should not be equated with proven safety in humans.

How does it work?

The pituitary secretes growth hormone in pulses regulated by two opposing signalling pathways:

1. GHRH (growth hormone-releasing hormone) stimulates synthesis and secretion.
2. Somatostatin inhibits secretion.

GH secretagogues act on various receptors in this axis. Ipamorelin acts via the ghrelin receptor, which can increase the amplitude of physiological pulses. An important consequence is that the effect is not the same as a constant hormone level, such as would be produced by direct administration of recombinant hGH.

What do the studies show?

Preclinical studies in animals and limited studies in humans have examined the effect on growth hormone secretion, body composition and some metabolic markers. The results were promising mainly in terms of pharmacodynamics — how strongly and for how long the hormone is secreted.

The clinical development of Ipamorelin did not lead to a widely approved medicine. This means that large, independent data on long-term safety, interactions and clinically meaningful outcomes are lacking. For researchers, precise protocols, measurements and comparison with a control group are therefore important.

The difference from growth hormone and steroids

Ipamorelin is not growth hormone and not a steroid. It is a peptide that acts on the body’s own endocrine signalling. This difference matters both biologically and in regulatory terms: the effects are indirect, depend on pituitary function and may differ from expectations shaped by studies with recombinant hGH.

We have written more about the differences between peptides and steroids in a separate article.

Safety and sport

GH secretagogues are often prohibited in competitive sport. If you operate in an environment where WADA rules or those of national federations apply, check the prohibited list. In addition, the long-term effect on hormonal balance has not been sufficiently researched.

Quality and storage

The listing declares a purity of ≥ 99 % (HPLC) and confirmed identity. Store the lyophilizate at −20 °C, protected from moisture and light. After reconstitution, follow the laboratory protocol and storage at 2–8 °C.

Conclusion

Ipamorelin is a well-described pharmacological instrument for studying the pituitary axis. Its research value lies in the mechanism, not in promises of physical transformation. Clinical safety and efficacy remain open questions.